Brief: Zhongzhi Pharmaceutical Sees FY Net Profit Up Over 25%
Jan 31 (Reuters) - Zhongzhi Pharmaceutical Holdings Ltd
3737.HK :
* GROUP IS EXPECTED TO RECORD A SIGNIFICANT INCREASE OF
APPROXIMATELY OVER 25% IN NET PROFIT FOR YEAR
* EXPECTED RESULT DUE TO SIGNIFICANT INCREASE IN SALES OF
OUR
MODERN CHINESE MEDICINE DECOCTION PIECES
Source text for Eikon: ID:nHKS70ft0F
Further company coverage: 3737.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Zhongzhi Pharmaceutical Holdings
See all newsBrief: Zhongzhi Pharmaceutical Expects Over 70% Decrease In 2025 Net Profit
Brief: Zhongzhi Pharmaceutical Expects 90% Decrease In HY Net Profit
Brief: Zhongzhi Pharmaceutical Posts HY Profit Attributable RMB83.4 Million
Brief: Zhongzhi Pharmaceutical Sees Decrease In Net Profit Of 40% For HY
Brief: Zhongzhi Pharmaceutical Declares Final Dividend Of HK3 Cents Per Share